Biomea Fusion Inc
For the period ended Jun 30, 2024. Filed Jul 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Jul 31, 2024
BMEA$0.55-8.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Operations and Comprehensive Loss
(in thousands, except share and per share data)
| Three Months Ended · Six Months Ended | ||||
|---|---|---|---|---|
| June 30, | June 30, | |||
| 2024 | 2023 | 2024 | 2023 | |
| Operating expenses: | ||||
| Research and development | $31,825 | $21,938 | $65,601 | $46,333 |
| General and administrative | 7,073 | 5,719 | 14,356 | 11,355 |
| Total operating expenses | 38,898 | 27,657 | 79,957 | 57,688 |
| Loss from operations | (38,898) | (27,657) | (79,957) | (57,688) |
| Interest and other income, net | 1,622 | 2,766 | 3,620 | 3,746 |
| Net loss | $(37,276) | $(24,891) | $(76,337) | $(53,942) |
| Other comprehensive loss: | ||||
| Unrealized gain (loss) on investments, net | — | — | — | 1 |
| Comprehensive loss | $(37,276) | $(24,891) | $(76,337) | $(53,941) |
| Net loss per common share, basic and diluted | $(1.03) | $(0.70) | $(2.12) | $(1.66) |
| Weighted-average number of common shares used to compute basic and diluted net loss per common share | 36,043,561 | 35,348,293 | 35,966,965 | 32,483,297 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.